Predict your next investment

Venture Capital
trinity-fund.com

See what CB Insights has to offer

Investments

13

About Trinity Innovation Fund

Trinity Innovation Fund focuses on biopharmaceutical industry investments.

Trinity Innovation Fund Headquarter Location

China Overseas Plaza, No. 8 Guanghua Dongli Chaoyang District

Beijing, Beijing,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Trinity Innovation Fund News

Suzhou Ribo Raises $29 Million for siRNA Drug Development

Dec 6, 2019

03:19 EST 6 Dec 2019 | ChinaBio Today Suzhou Ribo Life Science , a siRNA drug development company, raised $29 million in a series C1 financing led by Panlin Capital and Trinity Innovation Fund. Founded in 2007, Ribo formed a China JV in 2012 with Quark Pharma, a US siRNA company. The Quark JV produced Ribo's first China-approved therapy, a treatment for Ischemic Optic Neuropathy. The company claims expertise in small nucleic acid drug discovery, scale-up and production. Ribo, which has six Quark-partnered drug candidates plus four of its own molecules in development, says the siRNA treatments address multiple needs. More details.... Share this with colleagues:

Trinity Innovation Fund Investments

13 Investments

Trinity Innovation Fund has made 13 investments. Their latest investment was in Velavigo as part of their Seed VC on November 11, 2021.

CBI Logo

Trinity Innovation Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/15/2021

Seed VC

Velavigo

$50M

Yes

7

8/9/2021

Series B - II

Bluepha

$66.29M

No

5

6/14/2021

Series D

HiFiBiO Therapeutics

$75M

Yes

5

3/2/2021

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

2/26/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/15/2021

8/9/2021

6/14/2021

3/2/2021

2/26/2021

Round

Seed VC

Series B - II

Series D

Seed VC - II

Series B

Company

Velavigo

Bluepha

HiFiBiO Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$50M

$66.29M

$75M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

5

5

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.